Chargement en cours...
FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia
Acute Myeloid Leukaemia (AML) is a blood cancer, which affects the red blood cells in the bone marrow. Of the possible proteins that are affected in AML, fms-like tyrosine kinase 3 (FLT3) has long been recognized as a potential therapeutic target as it affects the other signaling pathways and leads...
Enregistré dans:
| Publié dans: | Bioinformation |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Biomedical Informatics
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6677903/ https://ncbi.nlm.nih.gov/pubmed/31435156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015104 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|